Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Trials|July 27, 2025
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and designMichael Dymock, James H McMahon, David Griffin, et al.
European Journal of Pediatrics|January 14, 2021
Nipple shield use does not impact sucking dynamics in breastfeeding infants of mothers with nipple painViviane Silva Coentro, Sharon Lisa Perrella, Ching Tat Lai, et al.
NPJ Vaccines|September 7, 2024
Applying causal inference and Bayesian statistics to understanding vaccine safety signals using a simulation studyEvelyn Tay, Michael Dymock, Laura Lopez, et al.
The Medical Journal of Australia|June 16, 2026
Short-Term Safety and Adverse Event Risk Profiles for SARS-CoV-2 Booster Vaccine Doses in Australian Adults: A Survey StudyEvelyn Tay, Michael Dymock, Lucy Dawes, et al.
Nutrients|June 2, 2021
Reduction in Maternal Energy Intake during Lactation Decreased Maternal Body Weight and Concentrations of Leptin, Insulin and Adiponectin in Human Milk without Affecting Milk Production, Milk Macronutrient Composition or Infant GrowthGabriela E Leghi, Merryn J Netting, Ching T Lai, et al.
Scientific Reports|May 14, 2021
Daily variation of macronutrient concentrations in mature human milk over 3 weeksGabriela E Leghi, Ching T Lai, Ardra Narayanan, et al.
The Medical Journal of Australia|July 5, 2022
The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021Lucy Deng, Catherine Glover, Michael Dymock, et al.
International Journal of Antimicrobial Agents|May 9, 2022
Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpointLaurens Manning, Sarah Metcalf, Michael Dymock, et al.
Vaccines|September 28, 2024
Short-Term Active Safety Surveillance of the Spikevax and Nuvaxovid Priming Doses in AustraliaRenee Reynolds, Evelyn Tay, Michael Dymock, et al.
Trials|July 17, 2024
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trialDavid W J Griffin, Michael Dymock, Germaine Wong, et al.
Pageof 3